| Literature DB >> 12589713 |
Svetlana E Moskalenko1, Svetlana V Chabelskaya, Sergei G Inge-Vechtomov, Michel Philippe, Galina A Zhouravleva.
Abstract
BACKGROUND: Termination of protein synthesis in eukaryotes involves at least two polypeptide release factors (eRFs) - eRF1 and eRF3. The highly conserved translation termination factor eRF1 in Saccharomyces cerevisiae is encoded by the essential gene SUP45.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12589713 PMCID: PMC150568 DOI: 10.1186/1471-2199-4-2
Source DB: PubMed Journal: BMC Mol Biol ISSN: 1471-2199 Impact factor: 2.946
Figure 1Schematic representation of Position of the mutations is indicated above the SUP45 gene. The numbers under the SUP45 gene correspond to amino acid positions whose codons were changed to premature stop codons. Numbers on the right of arrows correspond to the size of truncated eRF1 protein.
Figure 2Nonsense mutations in the A. Plate assays showing the growth of yeast strains bearing nonsense mutations in the SUP45 gene (101-1B-D1606, 102-1B-D1606, 104-1B-D1606, 105-1B-D1606, 107-1B-D1606) in the synthetic medium without histidine (SC-His), lysine (SC-Lys), adenine (SC-Ade) or tryptophan (SC-Trp) at 25°C compared with the parent strain 1B-D1606. The types of nonsense mutations in parent strain are denoted under media indications. SUP45 mutant alleles are indicated. Ten serial dilutions of yeast suspension of the same density were used. Five independent clones were tested, representative results are shown. B. Determination of the level of nonsense suppression in sup45-n mutants. UAA, UAG and UGA suppression levels were quantified by measuring β-galactosidase levels in the strains 1B-D1606 (wild type) as control and in mutants transformed with plasmids pUKC817, pUKC818 or pUKC819 bearing a specific stop codon (TAA, TAG or TGA, respectively) in frame that precedes lacZ gene. The efficiency of nonsense codon readthrough (%) was quantified as a ratio of β-galactosidase activity in cells harboring lacZ with stop codon to that in cells without a stop codon in-frame with the lacZ gene in pUKC815 plasmids. The same strains as in Fig. 2A were used. Results are the means of three separate experiments. C. Western blot showing the synthesis of full-length eRF1 (49 kDa) and truncated eRF1 proteins with predicted molecular mass 43.0 kDa, 35.2 kDa and 31.5 kDa for mutants 105, 107 and 104, respectively. (*) Indicates a non-specific band. A search of yeast proteome with the N-terminal peptide sequence that was used for antibody production, revealed the presence of one protein (methionyl-tRNA synthetase, GenBank accession number CAA24627) containing this sequence that has an expected molecular weight near 85 kDa. Cultures of the same strains as in (A) were grown to mid-log phase in medium selective for plasmid and ribosome fractions were prepared. The same amount of each sample was loaded per lane. Immunoblot analysis was performed using polyclonal antibodies directed against the N-terminal part of eRF1.
Figure 3Nonsense mutations in the Thermosensitivity of strains bearing sup45-n mutations. The same strains as in (2A) were tested on the rich medium (YPD) at 37°C.
Figure 4Nonsense mutations in the A. Strain 1A-D1628 bearing SUP45 disruption was co-transformed by pRS316/SUP45 and pRS315/sup45-n plasmids. The cotransformants bearing pRS316/SUP45 and vector pRS315 only were used as a negative control. The transformants were assayed for growth by plating on 5-FOA medium to select against the URA3 plasmid pRS316/SUP45 carrying a wild-type copy of SUP45. Ten serial dilutions of yeast suspensions of the same density were used. Five independent transformants for each combination were tested. Representative results are shown. B. Plate assays showing the growth of transformants of 1A-D1628 bearing pRS316/SUP45 or pRS316/sup45-n plasmids on the synthetic medium without adenine (SC-Ade) or tryptophan (SC-Trp) at 25°C. The strains were tested in the same way as in Fig. 2A. C. Western blot showing the expression of full-length eRF1 (49 kDa) and truncated eRF1 proteins in the same strains as in (B). D. Complementation of the SUP45 gene disruption in the strain 13A-Y23282 by sup45-n mutations. The transformants with vector pRS315 were used as a negative control. The same plasmids as in (A) were used.
The efficiency of maintenance of pRS315/SUP45 plasmid on SUP45::HIS3 [sup45-n] background
| Transformants of 1A-D1628 bearing plasmids a: | % of Ura+ Leu- colonies after rounds of selection: | ||
| pRS315 [ | pRS316 [ | I b | II c |
| 9.5 ± 1.1 | 11.0 ± 0.7 | ||
| 6.3 ± 0.8 | 10.9 ± 1.1 | ||
| 2.2 ± 0.7 | 4.3 ± 0.9 | ||
| 2.5 ± 0.9 | 12.1 ± 2.2 | ||
| 0.3 ± 0.2 | 15.6 ± 1.7 | ||
| 2.0 ± 0.3 | 5.0 ± 0.6 | ||
a Strain 1A-D1628 bearing disruption of the SUP45 gene (SUP45::HIS3) and the SUP45 gene on pRS315 plasmid was transformed with pRS316/sup45-n plasmids. b The frequency of pRS315/SUP45 loss in cotransformants was determined (I). c Transformants bearing only sup45-n plasmids were selected on SC- Ura medium, re-transformed with pRS315/SUP45 plasmid and the frequency of pRS315/SUP45 loss in cotransformants was determined again (II). At least 3 independent transformants were tested for each plasmid combinations. The average data with standard errors (± SE) are presented.
Nonsense mutations in SUP45 lead to decreased ascospore viability
| D1628 transformed with plasmids: | Plasmid stability % | Total number of tetrads | Tetrads with indicated number of viable spores | % of His+Ura+ segregants a | |||
| 4 | 3 | 2 | 1 | ||||
| pRS316/ | 71 | 49 | 7 | 19 | 22 | 1 | 27 |
| pRS316/ | 74 | 52 | 6 | 6 | 38 | 2 | 15 |
| pRS316/ | 71 | 30 | 1 | 1 | 26 | 2 | 5 |
| pRS316/ | 74 | 48 | 0 | 2 | 42 | 4 | 2 |
| pRS316/ | 72 | 35 | 0 | 0 | 32 | 3 | 0 |
| pRS316/ | 69 | 31 | 3 | 5 | 21 | 2 | 14 |
a The amount of His+Ura+ segregants is a characteristic of sup45-n allele presence (His+ is the marker for the SUP45 gene disruption and Ura+- for the pRS316 plasmid presence). The data correspond to the sum of two experiments but the cell number in nonviable colonies was calculated from only one (Table 3).
Nonsense mutations in SUP45 lead to the block of cell divisions after spore formation
| D1628 transformed with plasmids: | Total number of non-viable spores | Percentage of non-viable spores forming microcolony with following numbers of cells: | ||
| 5–20 | 3 – 4 | 1 | ||
| pRS316/ | 22 | 0 | 0 | 100 |
| pRS316/ | 68 | 3 | 1 | 96 |
| pRS316/ | 52 | 15 | 25 | 60 |
| pRS316/ | 64 | 8 | 28 | 64 |
| pRS316/ | 39 | 13 | 18 | 69 |
| pRS316/ | 25 | 24 | 8 | 68 |
Nonsense mutations in SUP45 support ascospore viability in presence of SUQ5
| Strain D1638 transformed with plasmids: | Total number of tetrads | Number of tetrads with viable spores | % of His+Ura+ segregants | |||
| 4 | 3 | 2 | 1 | |||
| pRS316/ | 35 | 8 | 12 | 14 | 1 | 32 |
| pRS316/ | 36 | 11 | 11 | 13 | 1 | 33 |
| pRS316/ | 31 | 9 | 10 | 11 | 1 | 35 |
| pRS316/ | 20 | 1 | 7 | 11 | 1 | 17 |
| pRS316/ | 36 | 6 | 10 | 18 | 2 | 30 |
| pRS316/ | 36 | 2 | 9 | 24 | 1 | 18 |
Figure 5Expression of A. Two-hybrid interactions. Strain HF7C was co-transformed with pGADGH plasmids carrying different sup45-n mutations and pGBT9/SUP35 plasmid. The interactions were tested by the extent of resistance to 3-AT. Ten serial dilutions of yeast suspensions of the same density were used. Five independent transformants for each combination were tested. Representative results are shown. B. Western blot showing the expression of full-length eRF1+Gal4 and truncated eRF1+Gal4 proteins with predicted molecular mass in the same transformants as at (A).
The efficiency of UAA-readthrough of sup45-n mutations depends on the base following stop codon
| Termination tetranucleotide | Level of eRF1 (% from wild type) | Natural occurrence in highly expressed genes (%) [ | |
| UAAG | 8 | 35.9 | |
| UAAU | 13 | 16.7 | |
| UAAU | 14 | 16.7 | |
| UAAC | 32 | 1.3 |